The family of accused Gilgo Beach serial killer Rex Heuermann has gotten a helping hand from an unexpected source: The ...

During a live event, Danielle M. Brander, MD, discussed use of zanubrutinib in high-risk chronic lymphocytic leukemia.

Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.

Kerri Rawson, daughter of BTK Killer Dennis Rader, met with the family of accused Gilgo Beach serial killer Rex Heuermann in ...

Panelists discuss how lower out-of-pocket costs resulting from ibrutinib’s inclusion in the Inflation Reduction Act (IRA) might improve the affordability and utilization of BTK inhibitor treatments in ...

Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association ...

With a distribution agreement in place and an option to acquire Contego Medical, Medtronic’s peripheral vascular division ki ...

During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

Multiple sclerosis is a long-term autoimmune disorder in which the immune system mistakenly attacks the protective sheath ...

Panelists discuss how the Inflation Reduction Act (IRA) might influence health care systems’ selection and utilization of Bruton tyrosine kinase (BTK) inhibitors, particularly through changes in ...